Oral potentially malignant disorders (conditions like oral lichen planus and oral leukoplakia) show consistent microbial dysbiosis, but no single bacterial signature reliably predicts cancer risk yet. Study design inconsistencies prevent drawing causal conclusions or clinical recommendations at this stage.
A systematic review of 56 studies examined whether changes in oral bacteria correlate with oral potentially malignant disorders (OPMDs): conditions that carry increased risk of progressing to oral squamous cell carcinoma. The review synthesized research on oral lichen planus (30 studies), oral leukoplakia (9 studies), and other precancerous oral conditions (17 studies). The researchers wanted to identify whether a consistent microbial signature exists across these conditions, which could eventually serve as a prognostic marker.
The most abundant bacterial phyla in OPMD patients were Firmicutes, Proteobacteria, and Fusobacteria, consistent with what we know about the oral microbiota in general. However, the direction and magnitude of change varied considerably depending on which specific OPMD subtype was being studied. What's notable is that pathogenic species like Porphyromonas and Prevotella showed increases in several studies, while commensal bacteria such as Streptococcus were often reduced. This pattern mirrors what researchers observe in other oral inflammatory and cancerous conditions. Whole unstimulated saliva was the most common specimen type, and 16S rRNA sequencing dominated the analytical methods used.
Despite these general patterns, the systematic review highlights a critical limitation: heterogeneity in study design, sampling methods, and analytical approaches was substantial. Some studies collected saliva, others swabbed specific oral sites; some used different bioinformatic pipelines; and sample sizes varied widely. This methodological variation matters because the same microorganism measured differently can yield conflicting results. Findings on microbial richness (total number of species) and diversity (evenness of distribution) were inconsistent across studies, sometimes showing reduced diversity in OPMD patients and sometimes showing no difference.
The authors conclude that while dysbiosis appears to be a common feature in OPMDs, no reproducible microbial signature has emerged that would allow clinicians to reliably identify which patients will progress to cancer. The evidence currently supports the concept that oral microbiome composition changes in these conditions, but causal relationships remain unclear, and the clinical utility of microbiome profiling as a prognostic tool is not yet established.
If you have been diagnosed with an oral potentially malignant disorder, this research suggests the oral microbiome may play a role in disease progression, but it does not yet translate into specific supplemental or behavioral interventions. The field is in the evidence-gathering phase rather than the treatment-application phase.
Current clinical management of OPMDs remains focused on conventional approaches: regular monitoring, elimination of tobacco and alcohol use, and management of local risk factors like sharp tooth edges or ill-fitting dentures. Smoking cessation and alcohol reduction remain evidence-based priorities if you use these substances.
The oral microbiome can be influenced by diet, oral hygiene, antimicrobial exposures, and systemic health. General oral health practices like regular brushing, flossing, and professional cleanings remain foundational. Some emerging research explores whether dietary changes, fermented foods, or probiotics might influence oral microbiota composition, but no specific microbiome-targeted interventions have been validated in OPMD populations. If you have an OPMD diagnosis, discuss monitoring frequency and any changes in your oral health with your dentist or oral pathologist.
Future research will likely focus on standardized sampling and analysis to create reproducible microbial signatures, longitudinal studies to clarify cause versus association, and validation of whether microbiome profiling adds prognostic value beyond clinical and histological assessment.
| Aspect | Details |
|---|---|
| Study type | Systematic review |
| Number of included studies | 56 human studies |
| Primary conditions examined | Oral lichen planus (30 studies), oral leukoplakia (9 studies), other OPMDs including oral submucous fibrosis and proliferative verrucous leukoplakia (17 studies) |
| Most common sampling method | Whole unstimulated saliva |
| Most common analytical method | 16S rRNA gene sequencing |
| Most abundant bacterial phyla | Firmicutes, Proteobacteria, Fusobacteria |
| Key microbes with changes | Increases in Porphyromonas and Prevotella; decreases in Streptococcus |
| Consistency of findings | Moderate for dysbiosis presence; inconsistent for richness/diversity measures; no reproducible signature across subtypes |
| Risk of bias assessment | Newcastle-Ottawa Scale |
Systematic review: "Alterations of oral microbiome in oral potentially malignant disorders: a systematic review" (BMC Oral Health, 2025) - https://pubmed.ncbi.nlm.nih.gov/42768338/
ProtocolEngine provides general health information based on published research. This is not medical advice. Consult a healthcare professional before starting any supplement or health protocol.
| Substantial heterogeneity in study design, sampling strategies, and analytical methods limits causal inference |
| Journal | BMC Oral Health |
| PubMed ID | 42768338 |
| Registration | PROSPERO CRD42024516735 |